Table 2 The correlation between clinical-pathological features and miR-1915-3p expression in 73 NSCLC patients
From: MicroRNA-1915-3p inhibits cell migration and invasion by targeting SET in non-small-cell lung cancer
miR-1915 Expression | ||||
|---|---|---|---|---|
Characteristics | NO. of cases | low | high | P value |
Age(y) | ||||
 < 60 | 34 | 22 (64.71%) | 12 (35.29%) | χ2 = 0.0782 |
 ≧60 | 39 | 24 (61.54%) | 15 (38.46%) | p = 0.7798 |
Gender | ||||
 Male | 48 | 31 (64.58%) | 17 (35.42%) | χ2 = 0.1482 |
 Female | 25 | 15 (60.00%) | 10 (40.00%) | p = 0.7003 |
Smoking history | ||||
 Yes | 34 | 22 (64.71%) | 12 (35.29%) | χ2 = 0.0782 |
 No | 39 | 24 (61.54%) | 15 (38.46%) | p = 0.7798 |
NSCLC types | ||||
 Squamous cell carcinoma | 34 | 19 (55.88%) | 15 (44.12%) | χ2 = 1.3887 |
 Adenocarcinoma | 39 | 27 (69.23%) | 12 (30.77%) | p = 0.2386 |
TNM classification | ||||
 I + II | 44 | 22 (50.00%) | 22 (50.00%) | χ2 = 8.0483 |
 III + IV | 29 | 24 (82.76%) | 5 (17.24%) | p = 0.0046a |
EGFR | ||||
 Del-19 | 18 | 12((66.67%) | 6 (33.33%) | χ2 = 0.2916 |
 L858R | 12 | 8 (66.67%) | 4 (33.33%) | p = 0.8643 |
 WT | 43 | 26 (60.47%) | 17 (39.53%) | |